Cost calculation model of introducing Upadacitinib and Risankizumab for adult ulcerative colitis and Crohn’s disease in the Kingdom of Saudi Arabia

Mahmoud H. Mosli; Abdulelah A. Almutairdi; Abdullah M. Alshahrani; Abdulrahman M. Alkhurmi; Ahmad N. Fasseeh; Ali M. Anwar; Bandar M. Alharbi; Esraa S. Altawil; Haneen J. Alshareef; Hussain A. Alqasim; Ibtisam H. Alharbi; Kareem A. El-Fass; Layla N. Alanizy; Rayd A. Almehizia; Rok Hren; Wael K. Iskandarani; Hana A. Alabdulkarim

doi:10.4103/sjg.sjg_245_25

الاقتباسات

393

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Mahmoud, H. M., Abdulelah, A. A., Abdullah, M. A., Abdulrahman, M. A., Ahmad, N. F., Ali, M. A., Bandar, M. A., Esraa, S. A., Haneen, J. A., Hussain, A. A., Ibtisam, H. A., Kareem, A. E., Layla, N. A., Rayd, A. A., Rok, H., Wael, K. I., Hana, A. A. (2025). Cost calculation model of introducing Upadacitinib and Risankizumab for adult ulcerative colitis and Crohn’s disease in the Kingdom of Saudi Arabia. Saudi Journal of Gastroenterology. https://doi.org/10.4103/sjg.sjg_245_25

Saleh A. Alqahtani; Faisal Abaalkhail; Saad Alghamdi; Khalid Bzeizi; Waleed K. A · 2024

استشهاد

397

CEBPB dampens the cuproptosis sensitivity of colorectal cancer cells by facilitating the PI3K/AKT/mT…

Tianchen Huang; Yong Zhang; Yachao Wu; Xiaodong Han; Lei Li; Zhipeng Guo; Kan Li · 2024

استشهاد

398

SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024

Abdullah S. Alghamdi; Hamdan Alghamdi; Haleema A. Alserehi; Mohammed A. Babatin; · 2024

استشهاد

396

The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real w…